Vaddi Krishna 13D and 13G filings for Prelude Therapeutics Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:19 pm Purchase |
2024-12-31 | 13G | Prelude Therapeutics Incorporated PRLD |
Vaddi Krishna | 5,489,130 9.500% |
581,044 (+11.84%) |
Filing |
| 2024-02-12 4:26 pm Purchase |
2023-12-31 | 13G | Prelude Therapeutics Incorporated PRLD |
Vaddi Krishna | 4,908,086 11.100% |
608,763 (+14.16%) |
Filing |
| 2023-02-10 08:00 am Purchase |
2022-12-31 | 13G | Prelude Therapeutics Incorporated PRLD |
Vaddi Krishna | 4,299,323 11.300% |
680,770 (+18.81%) |
Filing |
| 2022-02-04 4:05 pm Purchase |
2021-12-31 | 13G | Prelude Therapeutics Incorporated PRLD |
Vaddi Krishna | 3,618,553 9.700% |
680,781 (+23.17%) |
Filing |
| 2021-02-11 4:06 pm Purchase |
2020-12-31 | 13G | Prelude Therapeutics Incorporated PRLD |
Vaddi Krishna | 2,937,772 12.620% |
2,937,772 (New Position) |
Filing |